Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists-Reference-Cited by-同舟云学术

Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists

Published:2003-08 Issue:16 Volume:13 Page:2625-2628
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Baxter Andrew,Bennion Colin,Bent Janice,Boden Kerry,Brough Steve,Cooper Anne,Kinchin Elizabeth,Kindon Nicholas,McInally Tom,Mortimore Mike,Roberts Bryan,Unitt John

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference13 articles.

1. The Biology of Chemokines and their Receptors

2. Chemokine Receptor Antagonists

3. Chapter 17. Chemokines: Targets for novel therapeutics

4. Chemokines, chemokine receptors and small-molecule antagonists: recent developments

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists;Chemical Communications;2022

2. Direct Electrochemical Synthesis of Sulfur‐Containing Triazolium Inner Salts;Chinese Journal of Chemistry;2021-03-29

3. Targeting CXCR1/2: The medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead;European Journal of Medicinal Chemistry;2020-01

4. Lead Optimization in the Drug Discovery Process;Advances in Medical Technologies and Clinical Practice;2019

5. Tales of the Unexpected in Synthesis of Polyfunctional Heteroaromatics;Current Organic Synthesis;2018-07-05